Cargando…
Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
Objective: Cancer stem cell marker CD44 and its variant isoforms (CD44v) may be correlated with tumor growth, metastasis, and chemo-radiotherapy resistance. However, the prognostic power of CD44 and CD44v in advanced cancer remains controversial. Therefore, the purpose of our study was to generalize...
Autores principales: | Han, Susu, Huang, Tao, Li, Wen, Wang, Xiyu, Wu, Xing, Liu, Shanshan, Yang, Wei, Shi, Qi, Li, Hongjia, Hou, Fenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372530/ https://www.ncbi.nlm.nih.gov/pubmed/30788285 http://dx.doi.org/10.3389/fonc.2019.00039 |
Ejemplares similares
-
Prognostic value of ALDH1 and Nestin in advanced cancer: a systematic meta-analysis with trial sequential analysis
por: Han, Susu, et al.
Publicado: (2019) -
Prognostic Value of CD133 and SOX2 in Advanced Cancer
por: Han, Susu, et al.
Publicado: (2019) -
The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis
por: Han, Susu, et al.
Publicado: (2019) -
Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis
por: Han, Susu, et al.
Publicado: (2017) -
The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
por: Wang, Zhenpeng, et al.
Publicado: (2019)